Similarly, patients with hemophilia A have distinct HLA profiles that may differentially bind to the same fVIII peptide but consequently have disparate outcomes, with the same fVIII transgene inducing formation of Tregs in one patient and effector T cells in another. The gene discussed is F8; the disease is hemophilia A.